Abstract
Background and Aims: Dysbetalipoproteinemia (DBLP) is characterized by an accumulation in plasma of triglyceride (TG) rich lipoproteins resulting from the abnormal hepatic catabolism of very low-density lipoproteins (VLDL) and chylomicrons (QM) remnants. Non-HDL cholesterol/apolipoprotein B (apoB) ratio >1.43 (mg/dL) followed by APOE genotyping showed the best performance in the diagnosis of DBLP. AIM To analize the sensitivity and specificity of non-HDLc/apo B ratio in the diagnosis of DBLP in our population.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
